IX PADUA FACTOR ANTIBODIES Russian patent published in 2022 - IPC C07K16/34 C07K16/36 C12N5/10 C12N15/13 C12N15/63 G01N33/50 

Abstract RU 2770006 C2

FIELD: biotechnology.

SUBSTANCE: group of inventions is described, including an antibody or its antigen-binding fragment that binds IX Padua factor, polypeptide that binds IX Padua factor, a conjugate that binds IX Padua factor, containing the above-mentioned antibody or antigen-binding fragment, or polypeptide, nucleic acid, an expression vector, a host cell, a kit for the detection of IX Padua factor, a composition for the detection of IX Padua factor (options), use of antibodies or an antigen-binding fragment, polypeptide, a conjugate, nucleic acid, a vector, a host cell and a kit for the detection of IX Padua factor in a sample, and a method for the detection of IX Padua factor in a sample obtained from a subject. In one of embodiments, the antibody or its antigen-binding fragment contains an amino acid sequence SSYAIS (SEQ ID NO: 6); GIVPAFGTANYAQKFQG (SEQ ID NO: 7); SWGVISFAY (SEQ ID NO: 8); RASQDISSYLN (SEQ ID NO: 9); AASNLQS (SEQ ID NO: 10); and MQYDSLPFTF (SEQ ID NO: 11).

EFFECT: invention expands the arsenal of means for binding IX Padua factor.

49 cl, 32 dwg, 1 tbl, 5 ex

Similar patents RU2770006C2

Title Year Author Number
PROCOAGULANT ANTIBODIES 2018
  • Torn, Karina
  • Khansen, Byarne, Gram
  • Jonsen, Laust, Bruun
  • Kharndal, Mikkel, Nors
  • Yan, Chzhizhu
  • Estergaard, Khenrik
  • Grajsen, Per, J
  • Jokhansson, Eva
  • Rash, Morten, Grenbek
  • Chen, Dzyankhe
  • Svensson, Anders
  • Chzhu, Khajsun
  • Chzhou, Zhun
RU2810094C2
ADVANCED PROCOAGULANT ANTIBODIES 2019
  • Torn, Karina
  • Khansen, Byarne, Gram
  • Jonsen, Laust, Bruun
  • Kharndal, Mikkel, Nors
  • Yan, Chzhizhu
  • Estergaard, Khenrik
  • Grejzen, Per, Dzh
  • Jokhansson, Eva
  • Rash, Morten, Grenbekh
  • Chen, Tsziankhe
  • Svensson, Anders
  • Chzhu, Khajsun
  • Chzhou, Zhun
RU2810748C2
MULTI-SPECIFIC ANTIGEN-BINDING MOLECULE HAVING SUBSTITUTE FUNCTIONAL ACTIVITY OF BLOOD COAGULATING FACTOR VIII CO-FACTOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SPECIFIED MOLECULE AS ACTIVE INGREDIENT 2018
  • Teranishi Yuri
  • Kato Kazuki
  • Koga Hikaru
  • Igawa Tomoyuki
  • Yamaguchi Kazuki
  • Soeda Tetsuhiro
RU2812909C2
DOSING REGIMEN FOR TFPI ANTAGONISTS 2019
  • Zhu, Tong
  • Arkin, Steven
  • Cardinal, Matthew H.
  • Lim, Chay Ngee
  • Nayak, Satyaprakash
RU2780590C1
BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3 2018
  • Codarri Deak Laura
  • Fischer Jens
  • Imhof-Jung Sabine
  • Klein Christian
  • Seeber Stefan
  • Weber Patrick Alexander Aaron
  • Perro Mario
RU2778805C2
ANTIBODIES AGAINST XI CLOTTING FACTOR 2017
  • Chen Zhu
  • Ellsworth Kenneth P.
  • Milligan James A.
  • Oldham Elizabeth
  • Seiffert Dietmar
  • Ganti Vaishnavi
  • Tabrizifard Mohammad
  • Prinz Bianka
RU2757314C2
MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE 2016
  • Khaj Ketrin A.
  • Angela Khaver
RU2811445C2
COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS 2019
  • Tkaczyk, Christine
  • Sellman, Bret
  • Du, Qun
  • Damschroder, Melissa
  • Cohen, Taylor
RU2804815C2
DISPLAY OF AN INTEGRAL MEMBRANE PROTEIN ON EXTRACELLULAR ENVELOPED POXVIRUS VIRIONS 2017
  • Smith, Ernest S.
  • Paris, Mark
  • Scrivens, Maria G. M.
  • Kirk, Renee A.
  • Cornelison, Angelica A.
RU2759846C2
TETANUS TOXIN ANTIBODY AND USE THEREOF 2020
  • Liu Zhigang
  • Zhou Xiaowei
  • Liu Yulan
  • Hao Xiaobo
  • Hu Junjie
RU2815280C1

RU 2 770 006 C2

Authors

Voelkel, Dirk

Pachlinger, Robert

Rottensteiner, Hanspeter

Weber, Alfred

Engelmaier, Andrea

Dates

2022-04-14Published

2017-05-16Filed